| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.33 | 3e-10 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.22 | 5e-09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.29 | 8e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.31 | 9e-08 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.31 | 1e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |